Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharma company, has been drawing the market's attention after reporting positive results from advanced-stage clinical
Fate Therapeutics (FATE) looks headed for a turnaround post-COVID
Categories
Health Care
Novartis International AG (NVS) Q4 2020 Earnings Call Transcript
Novartis International AG (NYSE: NVS) Q4 2020 earnings call dated Jan. 26, 2021 Corporate Participants: Samir Shah -- Global Head, Investor Relations and Global
Johnson & Johnson (JNJ): Strength in ecommerce drives growth in Consumer Health
Shares of Johnson & Johnson (NYSE: JNJ) gained nearly 3% in morning trade on Tuesday after the company reported fourth quarter 2020
Johnson & Johnson (JNJ) beats market estimates in Q4
Johnson & Johnson (NYSE: JNJ) reported fourth-quarter 2020 financial results before the regular market hours on Tuesday. The pharmaceutical giant reported fourth-quarter
Merck (MRK) pulls out of the COVID-19 vaccine race; will focus on investigational therapeutic candidates
Merck & Co. Inc. (NYSE: MRK) has decided to discontinue the development of its COVID-19 vaccine candidates after its clinical trials yielded
Key highlights from Kimberly-Clark (KMB) Q4 2020 earnings results
Kimberly-Clark Corporation (NYSE: KMB) reported fourth-quarter 2020 earnings results today. Net sales increased 6% to $4.8 billion year-over-year. Net income attributable to
COVID-related medical costs may weigh on UnitedHealth’s performance this year
The health insurance sector has been facing multiple challenges from the virus crisis, but market-leading healthcare firm UnitedHealth Group (NYSE: UNH) maintained
Infographic: Intuitive Surgical Q4 earnings results
Intuitive Surgical (NASDAQ: ISRG) reported fourth-quarter 2020 financial results after the regular market hours on Thursday. The robotic product's manufacturer reported fourth-quarter
Latest study shows Eli Lilly’s (LLY) antibody reduces COVID-19 by 80%
Eli Lilly and Company (NYSE: LLY) announced that the results from its latest study indicated that its monoclonal antibody bamlanivimab reduced the
Codexis (CDXS) may be moving closer to profitability, after beating slowdown
Biosciences company Codexis, Inc. (NASDAQ: CDXS) has emerged stronger from a rough patch, supported mainly by the resilience of its partners to
CEO TALKS: The story of Trxade Group (MEDS)
Probably the biggest highlight of Trxade Group Inc (NASDAQ: MEDS) is that it was set up to solve the problems faced by
UnitedHealth Group, Inc. (UNH) Q4 2020 Earnings Call Transcript
UnitedHealth Group, Inc. (NYSE: UNH) Q4 2020 earnings call dated Jan. 20, 2021 Corporate Participants: David S. Wichmann -- Chief Executive Officer John Rex -- Office
Infographic: UnitedHealth Group (UNH) reports Q4 2020 earnings
UnitedHealth Group Incorporated (NYSE: UNH) reported fourth-quarter 2020 earnings results today. Revenues grew 7% to $65.5 billion year-over-year, helped by 21% growth
Covid vaccine won’t dent Ampio Pharma’s market: CEO Michael Macaluso
Since its foundation in 2008, Ampio Pharmaceuticals (NYSE: AMPE) has been focused on delivering a drug that treats inflammation caused by a
Johnson & Johnson’s (JNJ) COVID-19 vaccine would have an edge over others without this glitch
Johnson & Johnson (NYSE: JNJ) saw its shares climb 2% on Thursday after the company reported positive results from the early-stage trials
Rite Aid (RAD) looks to regain lost ground with new rebound strategy
Rite Aid Corporation (NYSE: RAD) is on a mission to put the house in order and achieve sustainable profitability, after prolonged volatility
Moderna (MRNA): Development programs, additional approvals provide optimism
Moderna Inc. (NASDAQ: MRNA) seems to be on a roll right now. The stock has skyrocketed over 500% in the past one
AngioDynamics Inc. (ANGO) Q2 2021 Earnings Call
AngioDynamics Inc. (NASDAQ: ANGO) Q2 2021 earnings call dated Jan. 07, 2021 Corporate Participants: Jim Clemmer — President and Chief Executive Stephen A. Trowbridge — Executive Vice
Walgreens Boots Alliance, Inc. (WBA) Q1 2021 Earnings Call
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) Q1 2021 earnings call dated Jan. 07, 2021 Corporate Participants: Gerald Gradwell — Senior Vice President of Special Projects
Trxade Group Inc. (NASDAQ: MEDS) Q4 2020 Research Summary
Ticker MEDSExchange NASDAQFounded 2013Headquarters FloridaIndustry TechnologyMarket Cap $45 million Trxade Group Inc (NASDAQ: MEDS) has been serving pharmacies and drug manufacturers for
Walgreens Boots Alliance, Inc. (WBA) Q1 2021 Earnings Call Transcript
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) Q1 2021 earnings call dated Jan. 07, 2021 Corporate Participants: Gerald Gradwell -- Senior Vice President of Special